MedTrace Logo

Whole Blood Transcriptomic Signal According to Coronary Atherosclerotic Plaque Burden Assessed by CT Angiography

NCT06194526 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-01-08

No results posted yet for this study

Summary

The present clinical study aims to identify transcriptomic patterns derived from whole blood samples related to coronary atherotic burden. Additionally, as a secondary analysis, the research team will explore the algorithm's ability to detect the presence of aortic disease and pro-inflammatory cardiometabolic alterations, such as hepatic steatosis and surrogate markers of coronary inflammation.

Conditions

  • Calcific Coronary Arteriosclerosis
  • Coronary Stenosis
  • Coronary Plaque
  • Aortic Calcification
  • Atherosclerotic Plaque

Sponsors & Collaborators

  • Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia

    collaborator OTHER

  • MultiplAI Health Limited

    lead OTHER

Principal Investigators

  • Rosana Poggio, MD MSc PhD · MultiplAI Health LTD

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-19
Primary Completion
2024-08-31
Completion
2028-09-30

Countries

  • Argentina

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06194526 on ClinicalTrials.gov